Recommendations for the development and validation of flow cytometry-based receptor occupancy assays.

about

Monitoring CD49d receptor occupancy: A method to optimize and personalize natalizumab therapy in multiple sclerosis patients.

P2860

Q48669278-88E83309-B12D-46F5-BAC1-2E0DBB507321

P2860

Recommendations for the development and validation of flow cytometry-based receptor occupancy assays.

Item

http://www.wikidata.org/entity/Q38632834

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Recommendations for the develo ...... sed receptor occupancy assays.

@en

type

Item

label

Recommendations for the develo ...... sed receptor occupancy assays.

@en

prefLabel

Recommendations for the develo ...... sed receptor occupancy assays.

@en

P1476

Recommendations for the develo ...... sed receptor occupancy assays.

@en

P2093

Alan Lackey

http://www.w3.org/2001/XMLSchema#string

Barry W A van der Strate

http://www.w3.org/2001/XMLSchema#string

Carl-Magnus Högerkorp

http://www.w3.org/2001/XMLSchema#string

Cherie L Green

http://www.w3.org/2001/XMLSchema#string

Danice E C Wilkins

http://www.w3.org/2001/XMLSchema#string

David Lanham

http://www.w3.org/2001/XMLSchema#string

Jennifer J Stewart

http://www.w3.org/2001/XMLSchema#string

John Ferbas

http://www.w3.org/2001/XMLSchema#string

Kamila Czechowska

http://www.w3.org/2001/XMLSchema#string

Maxime Moulard

http://www.w3.org/2001/XMLSchema#string

P2860

Receptor occupancy assessment by flow cytometry as a pharmacodynamic biomarker in biopharmaceutical development

Antimicrobial polypeptides of the human colonic epithelium

Why CCR2 and CCR5 blockade failed and why CCR1 blockade might still be effective in the treatment of rheumatoid arthritis

Phase I study of single-agent anti-programmed death-1 (MDX-1106) in refractory solid tumors: safety, clinical activity, pharmacodynamics, and immunologic correlates

Shipping blood to a central laboratory in multicenter clinical trials: effect of ambient temperature on specimen temperature, and effects of temperature on mononuclear cell yield, viability and immunologic function.

Quality assurance for polychromatic flow cytometry using a suite of calibration beads.

Pharmacokinetic/pharmacodynamic studies in drug product development.

Differentiating chronic lymphocytic leukemia from monoclonal B-lymphocytosis according to clinical outcome: on behalf of the GIMEMA chronic lymphoproliferative diseases working group

Clinical pharmacology of AMG 181, a gut-specific human anti-α4β7 monoclonal antibody, for treating inflammatory bowel diseases.

Recommendations for the validation of flow cytometric testing during drug development: I instrumentation.

P304

141-149

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/CYTO.B.21339

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-11-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26566147

http://www.w3.org/2001/XMLSchema#string

Recommendations for the development and validation of flow cytometry-based receptor occupancy assays.

about

P2860

P2860

Recommendations for the development and validation of flow cytometry-based receptor occupancy assays.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698